We’re proud to support UCI's anti-cancer challenge and Dr. Nagasaka’s groundbreaking research for our third consecutive year. Dr. Nagasaka has been an incredible resource and provider for our family during an unimaginably heavy time. Guiding us with compassion, clarity, and hope when we needed it most. Her dedication to advancing lung cancer research is not only saving lives but giving families like ours more time, more options, and more reasons to believe.

What began as an excruciating journey, waiting for test results and exploring treatment options, has transformed into one grounded in hope. Learning that our Aunt K is ALK-positive and finding Dr. Nagasaka has been a turning point. Her expertise and compassion have guided us every step of the way. Through her work, patients like Aunt K gain access to the most advanced targeted therapies available, helping to drive the breakthroughs that bring us closer to a cure.

This run is about more than raising funds, it’s about giving back to the research and people who are giving us hope. Every dollar raised supports the continued progress that makes stories like ours possible.

Read more about Dr. Nagasaka's Phase III study of utilizing Alectinib as a first line treatment for patients with ALK+ Lung Cancer: ucihealth.org/clinical-trials/UCI-24-192